4yfl - Revision history

OCA at 08:12, 3 May 2023

OCA — Wed, 03 May 2023 08:12:08 GMT

←Older revision		Revision as of 08:12, 3 May 2023
Line 3:		Line 3:
	<StructureSection load='4yfl' size='340' side='right'caption='[[4yfl]], [[Resolution\|resolution]] 3.39Å' scene=''>		<StructureSection load='4yfl' size='340' side='right'caption='[[4yfl]], [[Resolution\|resolution]] 3.39Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4yfl]] is a 6 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~9hiv1 9hiv1~~] and [~~http~~://en.wikipedia.org/wiki/Human ~~Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YFL OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4YFL FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4yfl]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YFL OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4YFL FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>~~</td></tr>~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-	~~<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">env ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=11676 9HIV1])~~</td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4yfl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yfl OCA], [https://pdbe.org/4yfl PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4yfl RCSB], [https://www.ebi.ac.uk/pdbsum/4yfl PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4yfl ProSAT]</span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4yfl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yfl OCA], [~~http~~://pdbe.org/4yfl PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4yfl RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4yfl PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4yfl ProSAT]</span></td></tr>	+
	</table>		</table>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/Q0ED31_9HIV1 Q0ED31_9HIV1]] The envelope glyprotein gp160 precursor down-modulates cell surface CD4 antigen by interacting with it in the endoplasmic reticulum and blocking its transport to the cell surface (By similarity).[RuleBase:RU004292][SAAS:SAAS000328_004_020447] The gp120-gp41 heterodimer allows rapid transcytosis of the virus through CD4 negative cells such as simple epithelial monolayers of the intestinal, rectal and endocervical epithelial barriers. Both gp120 and gp41 specifically recognize glycosphingolipids galactosyl-ceramide (GalCer) or 3' sulfo-galactosyl-ceramide (GalS) present in the lipid rafts structures of epithelial cells. Binding to these alternative receptors allows the rapid transcytosis of the virus through the epithelial cells. This transcytotic vesicle-mediated transport of virions from the apical side to the basolateral side of the epithelial cells does not involve infection of the cells themselves (By similarity).	+	[https://www.uniprot.org/uniprot/Q0ED31_9HIV1 Q0ED31_9HIV1] The envelope glyprotein gp160 precursor down-modulates cell surface CD4 antigen by interacting with it in the endoplasmic reticulum and blocking its transport to the cell surface (By similarity).[RuleBase:RU004292][SAAS:SAAS000328_004_020447] The gp120-gp41 heterodimer allows rapid transcytosis of the virus through CD4 negative cells such as simple epithelial monolayers of the intestinal, rectal and endocervical epithelial barriers. Both gp120 and gp41 specifically recognize glycosphingolipids galactosyl-ceramide (GalCer) or 3' sulfo-galactosyl-ceramide (GalS) present in the lipid rafts structures of epithelial cells. Binding to these alternative receptors allows the rapid transcytosis of the virus through the epithelial cells. This transcytotic vesicle-mediated transport of virions from the apical side to the basolateral side of the epithelial cells does not involve infection of the cells themselves (By similarity).
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 23:		Line 22:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: Human]]	+	[[Category: Homo sapiens]]
		+	[[Category: Human immunodeficiency virus 1]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Acharya, P]]	+	[[Category: Acharya P]]
-	[[Category: Kwong~~, P D~~]]	+	[[Category: Kwong PD]]
-	[[Category: Moquin, S]]	+	[[Category: Moquin S]]
-	[[Category: Zhou, T]]	+	[[Category: Zhou T]]
-	~~[[Category: Broadly neutralizing antibody]]~~	+
-	~~[[Category: Hiv-1 cd4 binding site]]~~	+
-	~~[[Category: Immune system~~]]	+

OCA at 06:58, 12 June 2019

OCA — Wed, 12 Jun 2019 06:58:36 GMT

←Older revision		Revision as of 06:58, 12 June 2019
Line 1:		Line 1:

	==Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 1B2530 in complex with HIV-1 clade A/E 93TH057 gp120==		==Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 1B2530 in complex with HIV-1 clade A/E 93TH057 gp120==
-	<StructureSection load='4yfl' size='340' side='right' caption='[[4yfl]], [[Resolution\|resolution]] 3.39Å' scene=''>	+	<StructureSection load='4yfl' size='340' side='right'caption='[[4yfl]], [[Resolution\|resolution]] 3.39Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4yfl]] is a 6 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YFL OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4YFL FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4yfl]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/9hiv1 9hiv1] and [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YFL OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4YFL FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">env ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=11676 9HIV1])</td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4yfl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yfl OCA], [http://pdbe.org/4yfl PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4yfl RCSB], [http://www.ebi.ac.uk/pdbsum/4yfl PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4yfl ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4yfl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yfl OCA], [http://pdbe.org/4yfl PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4yfl RCSB], [http://www.ebi.ac.uk/pdbsum/4yfl PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4yfl ProSAT]</span></td></tr>
	</table>		</table>
Line 22:		Line 23:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
		+	[[Category: Large Structures]]
	[[Category: Acharya, P]]		[[Category: Acharya, P]]
	[[Category: Kwong, P D]]		[[Category: Kwong, P D]]

OCA at 17:03, 22 March 2017

OCA — Wed, 22 Mar 2017 17:03:21 GMT

←Older revision		Revision as of 17:03, 22 March 2017
Line 1:		Line 1:
		+
	==Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 1B2530 in complex with HIV-1 clade A/E 93TH057 gp120==		==Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 1B2530 in complex with HIV-1 clade A/E 93TH057 gp120==
	<StructureSection load='4yfl' size='340' side='right' caption='[[4yfl]], [[Resolution\|resolution]] 3.39Å' scene=''>		<StructureSection load='4yfl' size='340' side='right' caption='[[4yfl]], [[Resolution\|resolution]] 3.39Å' scene=''>
Line 4:		Line 5:
	<table><tr><td colspan='2'>[[4yfl]] is a 6 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YFL OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4YFL FirstGlance]. <br>		<table><tr><td colspan='2'>[[4yfl]] is a 6 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YFL OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4YFL FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4yfl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yfl OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4yfl RCSB], [http://www.ebi.ac.uk/pdbsum/4yfl PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4yfl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yfl OCA], [http://pdbe.org/4yfl PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4yfl RCSB], [http://www.ebi.ac.uk/pdbsum/4yfl PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4yfl ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
Line 16:		Line 17:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 4yfl" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>

OCA at 07:28, 10 June 2015

OCA — Wed, 10 Jun 2015 07:28:51 GMT

←Older revision		Revision as of 07:28, 10 June 2015
Line 8:		Line 8:
	== Function ==		== Function ==
	[[http://www.uniprot.org/uniprot/Q0ED31_9HIV1 Q0ED31_9HIV1]] The envelope glyprotein gp160 precursor down-modulates cell surface CD4 antigen by interacting with it in the endoplasmic reticulum and blocking its transport to the cell surface (By similarity).[RuleBase:RU004292][SAAS:SAAS000328_004_020447] The gp120-gp41 heterodimer allows rapid transcytosis of the virus through CD4 negative cells such as simple epithelial monolayers of the intestinal, rectal and endocervical epithelial barriers. Both gp120 and gp41 specifically recognize glycosphingolipids galactosyl-ceramide (GalCer) or 3' sulfo-galactosyl-ceramide (GalS) present in the lipid rafts structures of epithelial cells. Binding to these alternative receptors allows the rapid transcytosis of the virus through the epithelial cells. This transcytotic vesicle-mediated transport of virions from the apical side to the basolateral side of the epithelial cells does not involve infection of the cells themselves (By similarity).		[[http://www.uniprot.org/uniprot/Q0ED31_9HIV1 Q0ED31_9HIV1]] The envelope glyprotein gp160 precursor down-modulates cell surface CD4 antigen by interacting with it in the endoplasmic reticulum and blocking its transport to the cell surface (By similarity).[RuleBase:RU004292][SAAS:SAAS000328_004_020447] The gp120-gp41 heterodimer allows rapid transcytosis of the virus through CD4 negative cells such as simple epithelial monolayers of the intestinal, rectal and endocervical epithelial barriers. Both gp120 and gp41 specifically recognize glycosphingolipids galactosyl-ceramide (GalCer) or 3' sulfo-galactosyl-ceramide (GalS) present in the lipid rafts structures of epithelial cells. Binding to these alternative receptors allows the rapid transcytosis of the virus through the epithelial cells. This transcytotic vesicle-mediated transport of virions from the apical side to the basolateral side of the epithelial cells does not involve infection of the cells themselves (By similarity).
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	The site on the HIV-1 gp120 glycoprotein that binds the CD4 receptor is recognized by broadly reactive antibodies, several of which neutralize over 90% of HIV-1 strains. To understand how antibodies achieve such neutralization, we isolated CD4-binding-site (CD4bs) antibodies and analyzed 16 co-crystal structures -8 determined here- of CD4bs antibodies from 14 donors. The 16 antibodies segregated by recognition mode and developmental ontogeny into two types: CDR H3-dominated and VH-gene-restricted. Both could achieve greater than 80% neutralization breadth, and both could develop in the same donor. Although paratope chemistries differed, all 16 gp120-CD4bs antibody complexes showed geometric similarity, with antibody-neutralization breadth correlating with antibody-angle of approach relative to the most effective antibody of each type. The repertoire for effective recognition of the CD4 supersite thus comprises antibodies with distinct paratopes arrayed about two optimal geometric orientations, one achieved by CDR H3 ontogenies and the other achieved by VH-gene-restricted ontogenies.
		+
		+	Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors.,Zhou T, Lynch RM, Chen L, Acharya P, Wu X, Doria-Rose NA, Joyce MG, Lingwood D, Soto C, Bailer RT, Ernandes MJ, Kong R, Longo NS, Louder MK, McKee K, O'Dell S, Schmidt SD, Tran L, Yang Z, Druz A, Luongo TS, Moquin S, Srivatsan S, Yang Y, Zhang B, Zheng A, Pancera M, Kirys T, Georgiev IS, Gindin T, Peng HP, Yang AS, Mullikin JC, Gray MD, Stamatatos L, Burton DR, Koff WC, Cohen MS, Haynes BF, Casazza JP, Connors M, Corti D, Lanzavecchia A, Sattentau QJ, Weiss RA, West AP Jr, Bjorkman PJ, Scheid JF, Nussenzweig MC, Shapiro L, Mascola JR, Kwong PD Cell. 2015 Jun 4;161(6):1280-92. doi: 10.1016/j.cell.2015.05.007. Epub 2015 May, 21. PMID:26004070<ref>PMID:26004070</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>

OCA at 12:47, 3 June 2015

OCA — Wed, 03 Jun 2015 12:47:29 GMT

←Older revision		Revision as of 12:47, 3 June 2015
Line 1:		Line 1:
-	'''~~Unreleased structure~~'''	+	==Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 1B2530 in complex with HIV-1 clade A/E 93TH057 gp120==
-		+	<StructureSection load='4yfl' size='340' side='right' caption='[[4yfl]], [[Resolution\|resolution]] 3.39Å' scene=''>
-	~~The entry~~ 4yfl is ~~ON HOLD until Paper Publication~~	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[4yfl]] is a 6 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YFL OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4YFL FirstGlance]. <br>
-	~~Authors~~: ~~Acharya, P~~., ~~Zhou, T~~., ~~Moquin, S~~., ~~Kwong, P~~.D.	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4yfl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yfl OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4yfl RCSB], [http://www.ebi.ac.uk/pdbsum/4yfl PDBsum]</span></td></tr>
-	~~Description~~: ~~Crystal structure of VH1-46 germline derived HIV~~-~~1 neutralizing antibody 1B2530 in complex~~ with ~~93TH057 gp120~~	+	</table>
-	[[~~Category~~: ~~Unreleased Structures]~~]	+	== Function ==
		+	[[http://www.uniprot.org/uniprot/Q0ED31_9HIV1 Q0ED31_9HIV1]] The envelope glyprotein gp160 precursor down-modulates cell surface CD4 antigen by interacting with it in the endoplasmic reticulum and blocking its transport to the cell surface (By similarity).[RuleBase:RU004292][SAAS:SAAS000328_004_020447] The gp120-gp41 heterodimer allows rapid transcytosis of the virus through CD4 negative cells such as simple epithelial monolayers of the intestinal, rectal and endocervical epithelial barriers. Both gp120 and gp41 specifically recognize glycosphingolipids galactosyl-ceramide (GalCer) or 3' sulfo-galactosyl-ceramide (GalS) present in the lipid rafts structures of epithelial cells. Binding to these alternative receptors allows the rapid transcytosis of the virus through the epithelial cells. This transcytotic vesicle-mediated transport of virions from the apical side to the basolateral side of the epithelial cells does not involve infection of the cells themselves (By similarity).
		+	__TOC__
		+	</StructureSection>
	[[Category: Acharya, P]]		[[Category: Acharya, P]]
-	[[Category: Kwong, P.D]]	+	[[Category: Kwong, P D]]
	[[Category: Moquin, S]]		[[Category: Moquin, S]]
	[[Category: Zhou, T]]		[[Category: Zhou, T]]
		+	[[Category: Broadly neutralizing antibody]]
		+	[[Category: Hiv-1 cd4 binding site]]
		+	[[Category: Immune system]]

OCA at 09:20, 30 April 2015

OCA — Thu, 30 Apr 2015 09:20:42 GMT

←Older revision		Revision as of 09:20, 30 April 2015
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4yfl is ON HOLD	+	The entry 4yfl is ON HOLD until Paper Publication

	Authors: Acharya, P., Zhou, T., Moquin, S., Kwong, P.D.		Authors: Acharya, P., Zhou, T., Moquin, S., Kwong, P.D.

OCA at 12:23, 26 March 2015

OCA — Thu, 26 Mar 2015 12:23:58 GMT

←Older revision		Revision as of 12:23, 26 March 2015
Line 3:		Line 3:
	The entry 4yfl is ON HOLD		The entry 4yfl is ON HOLD

-	Authors: Acharya, P., Zhou, T., Moquin, S, Kwong, P.D.	+	Authors: Acharya, P., Zhou, T., Moquin, S., Kwong, P.D.

	Description: Crystal structure of VH1-46 germline derived HIV-1 neutralizing antibody 1B2530 in complex with 93TH057 gp120		Description: Crystal structure of VH1-46 germline derived HIV-1 neutralizing antibody 1B2530 in complex with 93TH057 gp120
	[[Category: Unreleased Structures]]		[[Category: Unreleased Structures]]
-	[[Category: Moquin, S, Kwong, P.D]]
	[[Category: Acharya, P]]		[[Category: Acharya, P]]
		+	[[Category: Kwong, P.D]]
		+	[[Category: Moquin, S]]
	[[Category: Zhou, T]]		[[Category: Zhou, T]]

OCA: Protected "4yfl" [edit=sysop:move=sysop]

OCA — Wed, 04 Mar 2015 10:25:27 GMT

Protected "4yfl" [edit=sysop:move=sysop]

←Older revision

Revision as of 10:25, 4 March 2015

OCA: New page: '''Unreleased structure''' The entry 4yfl is ON HOLD Authors: Acharya, P., Zhou, T., Moquin, S, Kwong, P.D. Description: Crystal structure of VH1-46 germline derived HIV-1 neutralizing...

OCA — Wed, 04 Mar 2015 10:25:26 GMT

New page: '''Unreleased structure''' The entry 4yfl is ON HOLD Authors: Acharya, P., Zhou, T., Moquin, S, Kwong, P.D. Description: Crystal structure of VH1-46 germline derived HIV-1 neutralizing...

New page

'''Unreleased structure'''

The entry 4yfl is ON HOLD

Authors: Acharya, P., Zhou, T., Moquin, S, Kwong, P.D.

Description: Crystal structure of VH1-46 germline derived HIV-1 neutralizing antibody 1B2530 in complex with 93TH057 gp120
[[Category: Unreleased Structures]]
[[Category: Moquin, S, Kwong, P.D]]
[[Category: Acharya, P]]
[[Category: Zhou, T]]